Conclusion: Incompatibility of drug and nutrient injections is clinically ... acid is esterified with the position 21 OH group of methylprednisolone, and the hydrogen from the other succinic ...
An India man developed tuberculosis complications after starting treatment for rheumatoid arthritis, which doctors believe ...
Mineralys Therapeutics said on Monday its lead drug significantly lowered blood pressure in patients with difficult-to-treat hypertension in late- and mid-stage trials.
4d
News-Medical.Net on MSNInsilico Medicine's AI-driven drug Rentosertib receives official generic nameInsilico Medicine("Insilico"), a clinical stage generative artificial intelligence (AI)-driven biotechnology company, recently announced that its breakthrough drug candidate for idiopathic pulmonary ...
The FDA says state-licensed compounding pharmacies must immediately stop making compound versions of GLP-1 drugs. Larger, national licensed facilities making compound versions of Zepbound have until ...
Hyperemesis gravidarum affects 3% of pregnancies, causing severe vomiting and dehydration. Experts explain the causes, ...
A phase 3 trial for myelofibrosis found that adding pelebresib to ruxolitinib was more effective than ruxolitinib alone and did not significantly increase side effects.
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the generic pharmaceuticals stocks, including Amneal ...
The Food and Drug Administration (FDA) has approved Purified Cortrophin ® Gel (repository corticotropin injection USP) in a prefilled syringe presentation. Cortrophin Gel is a purified ...
The FDA has granted Breakthrough Therapy designation to radiprodil for the treatment of seizures associated with GRIN-related neurodevelopmental disorder with GoF mutations.
Here’s how it works. The best tablet for gamers, artists, young children, writers and editors are all going to be different. Then there's those top-tier tablets, the iPad Pro's and Tab s10 Ultra ...
A federal appeals court in the US has declined to overturn an attempt by Novartis to block the launch of a generic version of its blockbuster heart failure drug Entresto. The US Court of Appeals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results